Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x100px

Product › Details

P2MC technology (Paraxial Mesoderm Multipotent Cells)

	Next higher product group	cell therapy technology_o
	Status	2016-06-08 development existent
	Organisation	CRISPR Therapeutics AG (Nasdaq: CRSP)
	Group	CRISPR Therapeutics (Group)
	Organisation 2	Anagenesis Biotechnologies (FR)
	Today	Anagenesis (Group)
	Group	Anagenesis (Group)

Record changed: 2024-06-07

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

More documents for cell therapy technology_o

[1] Immatics N.V.. (10/10/22). "Press Release: Immatics Announces $110 Million Underwritten Offering of Ordinary Shares". Houston, TX & Tübingen....
[2] Immatics N.V.. (8/9/22). "Press Release: Immatics Announces Second Quarter 2022 Financial Results and Business Update". Tübingen & Houston, TX....
[3] Immatics N.V.. (6/7/22). "Press Release: Immatics and Editas Medicine Enter Strategic Research Collaboration and Licensing Agreement to Combine Gamma-Delta T Cell Adoptive Cell Therapies and Gene Editing for the Treatment of Cancer". Tübingen, Houston, T...
[4] Immatics N.V.. (6/2/22). "Press Release: Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs". Tübingen, Houston, TX & New York, NY....
[5] Agilent Technologies Inc.. (12/15/21). "Press Release: Lonza and Agilent Announce Strategic Collaboration to Integrate New Analytical Technologies with Lonza’s Cocoon Platform". Basel & Santa Clara, CA....
[6] BlueRock Therapeutics LP. (7/26/21). "Press Release: BlueRock Therapeutics Announces New Board Chair, New President and CEO". Cambridge, MA....
[7] Soteria Biotherapeutics, Inc.. (5/17/21). "Press Release: Soteria Biotherapeutics Launches with $42 Million Series A Financing Led by Roche Venture Fund and 5AM Ventures". San Francisco, CA....
[8] A2 Biotherapeutics, Inc.. (10/6/20). "Press Release: A2 Biotherapeutics Closes $71.5m Series B to Begin Clinical Development of Its Potentially TransformativeSelective Tumor Cell Therapeutics". Agoura Hills, CA....
[9] Lonza Group Ltd.. (9/8/20). "Press Release: Sheba Medical Center Treats First Patient with CAR-T Cell Immunotherapy Manufactured Using the Lonza Cell Immunotherapy Manufactured Using the Lonza Cocoon Platform". Basel & Tel Aviv....
[10] Bayer AG. (8/27/20). "Press Release: Bayer and Northpond Ventures Lead USD 55 Million Series A Financing Round for Triumvira Immunologics". Leverkusen & Austin, TX....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)